Art
J-GLOBAL ID:201702252318677925   Reference number:17A0963276

イマチニブが部分奏功したFIP1L1-PDGFRA陰性の慢性好酸球性白血病

Author (3):
Material:
Volume: 70  Issue:Page: 327-328  Publication year: Jul. 28, 2017 
JST Material Number: Z0002A  ISSN: 0367-5904  Document type: Article
Article type: 短報  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0963276&from=J-GLOBAL&jstjournalNo=Z0002A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Blood cell tumors(=neoplasms)  ,  Clinical oncology in general  ,  Clinical application of antitumor(=antineoplastic)drugs 
Reference (6):
  • Arber DA, Orazi A, Hasserjian R, et al.: The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood: 127: 2391-2405, 2016.
  • 田中英夫,木村昭郎 : 慢性好酸球性白血病 in 「免疫症候群 (第2版) II」, 別冊日本臨床 新領域別症候群シリーズ. No.35, 日本臨床社, 大阪, 2016: 274-279.
  • Baccarani M, Cilloni D, Rondoni M, et al.: The efficiency of imatinib mesylate in patients with FIP1L1-PDGFR alpha-positive hypereosinophilic syndrome. Result of a multicenter prospective study, Haematologica: 92: 1173-1179, 2007.
  • Cools J, DeAngelo DJ, Gotib J, et al.: A tyrosine kinase creative by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome, N Engl J Med: 348: 1201-1214, 2003.
  • David M, Cross NC, Burgstaller S, et al.: Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders, Blood: 109: 61-64, 2007.
more...
Terms in the title (2):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page